Invisible shield: sprayable supramolecular antimicrobial microscale films for preventing wound and medical device infections

Wound and device-associated infections remain difficult to eradicate because biofilms limit host immunity and antibiotic efficacy, promoting chronicity and resistance. Here, we present a portable, low-cost dual-syringe spray that deposits a thin, self-assembling antimicrobial film directly on wounds and implant surfaces. The device co-delivers oppositely charged hyaluronic acid (HA) and polyarginine (PAR30), a cationic antimicrobial peptide, which rapidly assembles into a conformal micrometric polyelectrolyte complex at the tissue-material interface. Molecular dynamics simulations revealed positional heterogeneity within the PAR30/HA complex and identified an N-terminal arginine as a dominant interaction hotspot. The resulting coating adheres to diverse substrates, kills bacteria on contact, prevents biofilm formation, and sustains antimicrobial efficacy. The treatment exhibited broad-spectrum in vitro activity against Gram-positive and Gram-negative pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. In murine wound infection models, the spray coating significantly reduced MRSA bacterial burden. The formulation was biocompatible, did not increase cutaneous inflammation or IL6 levels in vivo, and reduced post-surgical pain and motor deficits in a mouse incision model. Developed within a safe-and-sustainable-by-design framework, this technology offers a scalable, antibiotic-free strategy for wound-care and medical-device infection prevention.

Authors

Institutions

Publication Details

Journal
npj Biomedical Innovations.
Published
2026-10-28
DOI
https://doi.org/10.1038/s44385-026-00121-6
Primary Topic
Antimicrobial agents and applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Invisible shield: sprayable supramolecular antimicrobial microscale films for preventing wound and medical device infections

Merve Tunalı, Cynthia Calligaro, Thibaut Soubrié, Mélanie Kremer et al.
npj Biomedical Innovations.
Antimicrobial agents and applications
article

Invisible shield: sprayable supramolecular antimicrobial microscale films for preventing wound and medical device infections

Merve Tunalı, Cynthia Calligaro, Thibaut Soubrié, Mélanie Kremer, Skander Hathroubi, Philipp Meier, Noémie Willem, Sarah Jester, Lauriane Petit, Bernd Nowack, Giacomo Reina, David Grossin, Abdessalem Rekiki, Nihal Engin Vrana, Aurore Gaudin, Philippe Lavall�e, Christophe Drouet, Agnès Dupret‐Bories, Xavier Wurtz, Peter Wick, Aurélia Cès, Baptiste Letellier, Marjan Safarzadeh, Naomi Canourgues, Ophelie Heck, Lucie Lieu, Altan Demircan, Tetiana Goldanova, Derry Mercer, Yijie Li
article en

Abstract

Wound and device-associated infections remain difficult to eradicate because biofilms limit host immunity and antibiotic efficacy, promoting chronicity and resistance. Here, we present a portable, low-cost dual-syringe spray that deposits a thin, self-assembling antimicrobial film directly on wounds and implant surfaces. The device co-delivers oppositely charged hyaluronic acid (HA) and polyarginine (PAR30), a cationic antimicrobial peptide, which rapidly assembles into a conformal micrometric polyelectrolyte complex at the tissue-material interface. Molecular dynamics simulations revealed positional heterogeneity within the PAR30/HA complex and identified an N-terminal arginine as a dominant interaction hotspot. The resulting coating adheres to diverse substrates, kills bacteria on contact, prevents biofilm formation, and sustains antimicrobial efficacy. The treatment exhibited broad-spectrum in vitro activity against Gram-positive and Gram-negative pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. In murine wound infection models, the spray coating significantly reduced MRSA bacterial burden. The formulation was biocompatible, did not increase cutaneous inflammation or IL6 levels in vivo, and reduced post-surgical pain and motor deficits in a mouse incision model. Developed within a safe-and-sustainable-by-design framework, this technology offers a scalable, antibiotic-free strategy for wound-care and medical-device infection prevention.

npj Biomedical Innovations.Vol. 3(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Institut National Polytechnique de Toulouse (FR), Centre Hospitalier Universitaire de Toulouse (FR), Institut universitaire du cancer de Toulouse Oncopole (FR), Institut des Neurosciences Cellulaires et Intégratives (FR), Centre Interuniversitaire de Recherche et d’Ingénierie des Matériaux (FR), BIOASTER (FR), Biomatériaux et Bioingénierie (FR), Université de Strasbourg (FR), Swiss Federal Laboratories for Materials Science and Technology (CH)
Openalex Percentile: Top 26%
Antimicrobial agents and applications
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon